Lifting the lid on unborn lethal Mendelian phenotypes through exome sequencing

Genet Med. 2013 Apr;15(4):307-9. doi: 10.1038/gim.2012.130. Epub 2012 Oct 4.

Abstract

Purpose: Mendelian phenotypes in humans vary from benign variants to lethal disorders. Embryonic lethal phenotypes that are similar to what has been known for a long time in mice have remained largely unknown because of the difficulty in arriving at a molecular diagnosis. The purpose of this study is to test whether next generation sequencing can reveal the underlying etiology of recurrent fetal loss.

Methods: We hypothesized that exome sequencing combined with autozygome analysis can reveal the underlying mutation in a family in which recurrent fetal loss was likely to be autosomal recessive in origin.

Results: A novel mutation in CHRNA1 was identified. This gene is known to cause multiple pterygium and fetal akinesia syndrome.

Conclusion: This is the first report of exome sequencing to identify the cause of recurrent fetal loss and reveal the diagnosis of a lethal human phenotype. Our results should inspire a systematic examination of the extent of "unborn" Mendelian phenotypes in humans using next-generation sequencing.

Publication types

  • Case Reports

MeSH terms

  • Abortion, Habitual / diagnosis*
  • Abortion, Habitual / etiology*
  • Amino Acid Sequence
  • Base Sequence
  • Consanguinity
  • Consensus Sequence
  • Exome*
  • Female
  • Fetal Death / diagnosis*
  • Fetal Death / etiology*
  • High-Throughput Nucleotide Sequencing*
  • Humans
  • Hydrops Fetalis / genetics
  • Molecular Sequence Data
  • Phenotype*
  • Receptors, Nicotinic / genetics
  • Sequence Alignment
  • Young Adult

Substances

  • CHRNA1 protein, human
  • Receptors, Nicotinic